It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Acute caffeine intake has been found to increase working memory (WM)-related brain activity in healthy adults without improving behavioral performances. The impact of daily caffeine intake—a ritual shared by 80% of the population worldwide—and of its discontinuation on working memory and its neural correlates remained unknown. In this double-blind, randomized, crossover study, we examined working memory functions in 20 young healthy non-smokers (age: 26.4 ± 4.0 years; body mass index: 22.7 ± 1.4 kg/m2; and habitual caffeine intake: 474.1 ± 107.5 mg/day) in a 10-day caffeine (150 mg × 3 times/day), a 10-day placebo (3 times/day), and a withdrawal condition (9-day caffeine followed by 1-day placebo). Throughout the 10th day of each condition, participants performed four times a working memory task (N-Back, comprising 3- and 0-back), and task-related blood-oxygen-level-dependent (BOLD) activity was measured in the last session with functional magnetic resonance imaging. Compared to placebo, participants showed a higher error rate and a longer reaction time in 3- against 0-back trials in the caffeine condition; also, in the withdrawal condition we observed a higher error rate compared to placebo. However, task-related BOLD activity, i.e., an increased attention network and decreased default mode network activity in 3- versus 0-back, did not show significant differences among three conditions. Interestingly, irrespective of 3- or 0-back, BOLD activity was reduced in the right hippocampus in the caffeine condition compared to placebo. Adding to the earlier evidence showing increasing cerebral metabolic demands for WM function after acute caffeine intake, our data suggest that such demands might be impeded over daily intake and therefore result in a worse performance. Finally, the reduced hippocampal activity may reflect caffeine-associated hippocampal grey matter plasticity reported in the previous analysis. The findings of this study reveal an adapted neurocognitive response to daily caffeine exposure and highlight the importance of classifying impacts of caffeine on clinical and healthy populations.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 University Psychiatric Clinics Basel, Centre for Chronobiology, Basel, Switzerland (GRID:grid.412556.1) (ISNI:0000 0004 0479 0775); University of Basel, Transfaculty Research Platform Molecular and Cognitive Neurosciences, Basel, Switzerland (GRID:grid.6612.3) (ISNI:0000 0004 1937 0642); Psychiatric Hospital of the University of Basel, Neuropsychiatry and Brain Imaging, Basel, Switzerland (GRID:grid.412556.1) (ISNI:0000 0004 0479 0775)
2 University Psychiatric Clinics Basel, Centre for Chronobiology, Basel, Switzerland (GRID:grid.412556.1) (ISNI:0000 0004 0479 0775); University of Basel, Transfaculty Research Platform Molecular and Cognitive Neurosciences, Basel, Switzerland (GRID:grid.6612.3) (ISNI:0000 0004 1937 0642)
3 University of Zurich, Institute of Pharmacology and Toxicology, Zurich, Switzerland (GRID:grid.7400.3) (ISNI:0000 0004 1937 0650); University Center of Competence, University of Zurich, Sleep and Health Zurich, Zurich, Switzerland (GRID:grid.7400.3) (ISNI:0000 0004 1937 0650)
4 University Hospital Basel, Division of Radiological Physics, Department of Radiology, Basel, Switzerland (GRID:grid.410567.1); University of Basel, Department of Biomedical Engineering, Basel, Switzerland (GRID:grid.6612.3) (ISNI:0000 0004 1937 0642)
5 University Psychiatric Clinics Basel, Centre for Chronobiology, Basel, Switzerland (GRID:grid.412556.1) (ISNI:0000 0004 0479 0775); Psychiatric Hospital of the University of Basel, Clinical Sleep Laboratory, Basel, Switzerland (GRID:grid.412556.1) (ISNI:0000 0004 0479 0775)
6 Psychiatric Hospital of the University of Basel, Neuropsychiatry and Brain Imaging, Basel, Switzerland (GRID:grid.412556.1) (ISNI:0000 0004 0479 0775)